Pepcid and Stromectol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pepcid (famotidine) and Stromectol (ivermectin). Common drug interactions include chronic kidney disease among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Pepcid and Stromectol. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.

What is Stromectol?

Stromectol has active ingredients of ivermectin. eHealthMe is studying from 3,361 Stromectol users. Check the latest studies of Stromectol.

On Jul, 11, 2026

14 people who take Pepcid and Stromectol together, and have interactions are studied.

Pepcid and Stromectol drug interactions.

What are the common drug interactions of Pepcid and Stromectol, by gender? *:

female:

Chronic kidney disease
Renal failure (kidney dysfunction)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
Neuropathy peripheral (surface nerve damage)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Therapeutic response unexpected
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Pneumonia

male:

Acute respiratory failure
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Alanine aminotransferase increased
Altered state of consciousness (altered state of mind)
Aspartate aminotransferase increased
Atelectasis (partial or complete collapse of the lung)
Blood bilirubin increased
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)

What are the common drug interactions of Pepcid and Stromectol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Renal failure (kidney dysfunction)

40-49:

Acute respiratory failure
Renal impairment (severely reduced kidney function)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Pneumonia
Pyrexia (fever)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Atelectasis (partial or complete collapse of the lung)
Blood bilirubin increased

50-59:

n/a

60+:

Hypercalcaemia (elevated calcium (ca+) level in the blood)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Gastric disorder (disease of stomach)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
Pneumonia
Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

High Blood Pressure: 8 people, 57.14%
Acarodermatitis (skin inflammation caused by mites (acarids)): 6 people, 42.86%
Carotid Artery Stenosis (narrowing of carotid artery): 3 people, 21.43%
Constipation: 3 people, 21.43%
Diabetes: 3 people, 21.43%
Dizziness: 3 people, 21.43%
Calculus Urinary (stone in urinary system): 3 people, 21.43%
Gastritis (inflammation of stomach): 3 people, 21.43%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 21.43%
Hyperkalemia (damage to or disease of the kidney): 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid and Stromectol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously